Author:
Steinke-Lange Verena,Holinski-Feder Elke
Publisher
Springer Science and Business Media LLC
Reference12 articles.
1. Bläker H, Haupt S, Morak M et al (2020) Age-dependent performance of BRAF mutation testing in lynch syndrome diagnostics. Intl Journal of Cancer 147:2801–2810. https://doi.org/10.1002/ijc.33273
2. Dominguez-Valentin M, Haupt S, Seppälä TT et al (2023) Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database. EClinicalMedicine 58:101909. https://doi.org/10.1016/j.eclinm.2023.101909
3. Engel C, Vasen HF, Seppälä T et al (2018) No Difference in colorectal cancer incidence or stage at detection by colonoscopy among 3 countries with different lynch syndrome surveillance policies. Gastroenterology 155:1400–1409.e2. https://doi.org/10.1053/j.gastro.2018.07.030
4. Ahadova A, Seppälä TT, Engel C et al (2021) The “unnatural” history of colorectal cancer in lynch syndrome: lessons from colonoscopy surveillance. Intl Journal of Cancer 148:800–811. https://doi.org/10.1002/ijc.33224
5. Hüneburg R, Aretz S, Büttner R et al Empfehlungen zur Früherkennung, Risikoreduktion, Überwachung und Therapie bei Patienten mit Lynch-Syndrom. Z Gastroenterol 12: (Current recommendations for surveillance, risk reduction and therapy in Lynch syndrome patients)